More than 40 years after the first AIDS cases, new long-acting drugs and antibody-based therapies are reviving hopes that HIV ...

New EACS 2025 data show once-weekly islatravir and lenacapavir maintain HIV viral suppression for 96 weeks with no resistance ...

ViiV Healthcare, a healthcare company founded by Pfizer (NYSE:PFE) and GSK (NYSE:GSK), announced on Wednesday that its ...

HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as ...

A new study led by researchers at the George Washington University and published through the DC Cohort, one of the largest HIV longitudinal studies in the United States, finds that nearly half of ...

In what may be one of the most important HIV research breakthroughs in years, scientists have discovered a strikingly ...

The first symptoms of HIV are often similar to the flu, including fever, fatigue, and body aches. However, some people don't ...

South Africa’s fight against HIV/AIDS has received a boost with the USA government’s approval of the US President’s Emergency ...

Community advocates, health providers and local leaders in Charleston are all joining forces Wednesday in observance of ...

Those who had at least 1 inpatient insurance claim for HIV-related treatment or unrelated treatment with an HIV diagnosis were considered to be living with HIV. Receiving 1 or more opioid ...

This tiny nation was winning in its fight against HIV. Then Trump cut foreign aid - With the single stroke of Trump’s pen, ...